Still Pursuing Answers
ABTA Founder Susan Kramer reflects on the last 50 years and her unrelenting pursuit toward finding a cure.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
ABTA Founder Susan Kramer reflects on the last 50 years and her unrelenting pursuit toward finding a cure.
We need 500 people to donate or share their story for the ABTA’s first Day of Giving during Brain Tumor Awareness Month. Are you in?
See what’s igniting hope at the nation’s largest brain tumor conference and how you can get involved.
David Hou is awarded for his research on leveraging a B cell vaccine to improve immunotherapy treatment for GBM.
**Sponsored Content**
For adult patients with recurrent GBM, a new clinical trial may offer access to emerging solutions and novel therapies unavailable elsewhere.
Meet the newly-appointed ABTA Board Chair and Member and discover what they’re hopeful for in their new roles.
On November 17, 2022, results from a phase 3 trial of DCVax-L, an immunotherapy for glioblastoma patients, were published in the Journal of the American Medical Association (JAMA) Oncology.
Vince Rock answers the top questions he receives from patients and caregivers who call the ABTA CareLine.
In his own words, caregiver and musician Scott Ingersoll shares how he used music to channel his wife’s journey battling astrocytoma.
Always free for patients & caregivers
American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631